1. CCL20 Promotes Ovarian Cancer Chemotherapy Resistance by Regulating ABCB1 Expression
   Shan Su et al, 2019, Cell Structure and Function CrossRef
2. Animal-Based Materials in the Formulation of Nanocarriers for Anticancer Therapeutics
   R. Jayachandra Babu et al, 2019, Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics CrossRef
3. Engineering of Self-assembly Polymers Encapsulated with Dual Anticancer Drugs for the Treatment of Endometrial Cancer
   Ting-ting Chen et al, 2022, Journal of Cluster Science CrossRef
4. Potential Ecotoxicological Risk of Nanopharmaceuticals in the Aquatic Environment
   Maria João Bebianno et al, 2021, Nanopharmaceuticals: Principles and Applications Vol. 2 CrossRef
5. Deciphering the functional role of clinical mutations in ABCB1, ABCC1, and ABCG2 ABC transporters in endometrial cancer
   Aayushi Gupta et al, 2024, Frontiers in Pharmacology CrossRef
6. Polymeric Nanocarriers Loaded with a Combination of Gemcitabine and Salinomycin: Potential Therapeutics for Liver Cancer Treatment
   Gang Xu et al, 2023, Journal of Cluster Science CrossRef
7. Combinatory therapy of MRP1-targeted photoimmunotherapy and liposomal doxorubicin promotes the antitumor effect for chemoresistant small cell lung cancer
   Fang Li et al, 2022, International Journal of Pharmaceutics CrossRef
8. Assessment of spatial transcriptomics for oncology discovery
   Anna Lyubetskaya et al, 2022, Cell Reports Methods CrossRef
9. Interplay between MAP kinases and tumor microenvironment: Opportunity for immunotherapy in pancreatic cancer
   Sandeep Kumar et al, 2023, Pancreatic Cancer: Basic Mechanisms and Therapies CrossRef
10. The Effect of Nano Albumin Combined with Paclitaxel on Drug Resistance of Breast Cancer Through Regulating ATP Binding Cassette Subfamily B Member 1 (ABCB1)
    Tao Liu et al, 2022, Journal of Biomaterials and Tissue Engineering CrossRef
11. Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux
    Clarissa Willers et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
12. Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity
    Sebastian Pieper et al, 2019, Beilstein Journal of Nanotechnology CrossRef
13. A new niclosamide derivatives‐B17 can inhibit urological cancers growth through apoptosis‐related pathway
    Chia‐Lun Wu et al, 2018, Cancer Medicine CrossRef
14. Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
    Hannah Onafuye et al, 2019, Beilstein Journal of Nanotechnology CrossRef
15. Overexpressed ITGA2 contributes to paclitaxel resistance by ovarian cancer cells through the activation of the AKT/FoxO1 pathway
    Linlin Ma et al, 2020, Aging CrossRef
16. P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors
    Chengqiong Mao et al, 2018, Journal of Controlled Release CrossRef